Related Experiment Video
Updated: Jul 13, 2026
11:45
Quantifying Agonist Activity at G Protein-coupled Receptors
Published on: December 26, 2011
Mechanisms underlying agonist efficacy.
1School of Pharmacy, University of Reading, Whiteknights, Reading RG6 6AJ, UK. P.G.Strange@rdg.ac.uk
Biochemical Society Transactions
|July 20, 2007
Summary
Agonist efficacy, a measure of receptor stimulation, is effectively determined using the guanosine 5'-[gamma-[(35)S]thio]triphosphate-binding assay. This method quantifies agonist efficacy by measuring bound ligand, not binding rate.
Area of Science:
- Pharmacology
- Biochemistry
- Molecular Biology
Background:
- Agonist efficacy quantifies receptor response, with parameters like Emax and EC50 used for assessment.
- The Emax.KA/EC50 parameter offers a comprehensive efficacy estimate.
- G-protein-coupled receptor (GPCR) activation involves GTP binding, a process central to receptor signaling.
Purpose of the Study:
- To detail the utility of the guanosine 5'-[gamma-[(35)S]thio]triphosphate ([(35)S]GTP[S])-binding assay for profiling agonist efficacy.
- To elucidate the underlying mechanisms and kinetics of the [(35)S]GTP[S]-binding assay.
- To establish an efficacy scale for the D2 dopamine receptor using this assay.
Main Methods:
- Utilizing the [(35)S]GTP[S]-binding assay to measure agonist efficacy at receptors.
- Employing functional assays to determine efficacy parameters such as Emax, KA/EC50, and Emax.KA/EC50.
- Investigating the kinetics of [(35)S]GTP[S] binding to GPCRs.
Main Results:
- The [(35)S]GTP[S]-binding assay provides a convenient method for assessing agonist efficacy.
- The binding of [(35)S]GTP[S] to GPCRs follows pseudo-first-order kinetics, reaching equilibrium around 3 hours.
- Agonists modulate the maximal level of [(35)S]GTP[S] bound, with this binding event being rate-limiting.
- The assay determines efficacy based on the extent of [(35)S]GTP[S] binding, not the binding rate.
Conclusions:
- The [(35)S]GTP[S]-binding assay is a reliable tool for determining agonist efficacy, particularly for GPCRs.
- Understanding the assay's kinetics confirms that maximal [(35)S]GTP[S] binding reflects agonist efficacy.
- This assay facilitates the creation of efficacy scales, as demonstrated with the D2 dopamine receptor.
More Related Videos
09:05Measurement of Smooth Muscle Function in the Isolated Tissue Bath-applications to Pharmacology Research
Published on: January 19, 2015
07:41A Kinetic Fluorescence-based Ca2+ Mobilization Assay to Identify G Protein-coupled Receptor Agonists, Antagonists, and Allosteric Modulators
Published on: February 20, 2018
Related Concept Videos
01:25Drug-Receptor Interaction: Agonist
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous ligand's action.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous ligand's action.
01:29Drug-Receptor Interactions
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue.
01:16Adrenergic Agonists: Chemistry and Structure-Activity Relationship
Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of the aromatic...
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of the aromatic...
01:22Dose-Response Relationship: Potency and Efficacy
The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it produces...
01:29The Two-State Receptor Model
The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with one...
The binding affinity of a drug determines its interaction with one...
01:14Agonism and Antagonism: Quantification
When drugs are administered, they can elicit either an agonist or antagonist effect on the body. Agonism occurs when a drug activates a specific receptor, triggering a biological response. On the other hand, antagonism happens when a drug binds to the same receptors but blocks their activation, thereby preventing a biological response.
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...